Journal List > J Korean Ophthalmol Soc > v.59(4) > 1010881

Lee, Moon, Ji, and Yoon: Treatment Outcome of Wbund Infection after Cataract Surgery and Risk Factors of Treatment Failure

Abstract

Purpose

To evaluate factors affecting wound infection after cataract surgery, and treatment outcomes.

Methods

In this retrospective study, we included 20 patients (20 eyes) who experienced wound infection after cataract surgery (phacoemulsification with intraocular lens implantation) between January 2005 and January 2017. Only those who yielded positive microbial smears were selected. All patients were assigned to a “treatment success group” (remission of infection) or a “treatment failure group” (aggravation of infection or a need for surgical intervention to treat an infectious complication). The demographic, clinical and microbiological features of the two groups were compared and binary logistic regression analyses were performed to identify factors affecting treatment failure.

Results

Wound infection developed at 12.25 ± 20.21 days (range 5 to 45 days) after cataract surgery. Sixteen patients developed bacterial and four developed fungal keratitis. Of the 20 patients, 13 (65.0%) were treated successfully and 7 (35.0%) were not. In univariate analyses, diabetes (p = 0.035), incisional suturing (p = 0.038), combined endophthalmitis (p = 0.001), and fungal infection (p = 0.021) were associated with treatment failure. Multivariate analyses showed that combined endophthalmitis (p = 0.001) and fungal infection (p = 0.044) were significant risk factors for treatment failure.

Conclusions

Cataract wound infection is rare but constitutes a serious complication. Combined endophthalmitis and fungal infection are associated with poor treatment outcomes.

REFERENCES

1). Aaberg TM Jr, Flynn HW Jr, Schiffman J, et al. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology. 1998; 105:100410.
2). Valenton M. Wound infection after cataract surgery. Jpn J Ophthalmol. 1996; 40:447–55.
3). Lopez PF, Beldavs RA, al-Ghamdi S, et al. Pneumococcal endophthalmitis associated with nasolacrimal obstruction. Am J Ophthalmol. 1993; 116:56–62.
crossref
4). Cosar CB, Cohen EJ, Rapuano CJ, Laibson PR. Clear corneal wound infection after phacoemulsification. Arch Ophthalmol. 2001; 119:1755–9.
crossref
5). Maxwell DP Jr, Diamond JG, May DR. Surgical wound defects associated with endophthalmitis. Ophthalmic Surg. 1994; 25:157–61.
crossref
6). Chiang RK, Rapuano CJ. Recurrent methicillin-resistant Staphylococcus aureus wound ulcer after clear-cornea cataract surgery. CLAO J. 2002; 28:109–10.
7). Yamamoto N, Matsumoto T, Ishibashi Y. Fungal keratitis caused by Colletotrichum gloeosporioides. Cornea. 2001; 20:902–3.
crossref
8). McDonnell PJ, Werblin TP, Sigler L, Green WR. Mycotic keratitis due to Beauveria alba. Cornea. 1984-1985; 3:213–6.
crossref
9). Kau HC, Tsai CC, Kao SC, Liu JH. Corneal ulcer of the side port after phacoemulsification induced by Acinetobacter baumannii. J Cataract Refract Surg. 2002; 28:895–7.
crossref
10). Rao SK, Madhavan HN, Sitalakshmi G, Padmanabhan P. Norcardia asteroids keratitis: report of seven patients and literature review. Indian J Ophthalmol. 2000; 48:217–21.
11). Driebe WT Jr, Mandelbaum S, Forster RK, et al. Pseudophakic endophthalmitis. Diagnosis and management. Ophthalmology. 1986; 93:442–8.
12). Scott IU, Flynn HW Jr, Feuer W. Endophthalmitis after secondary intraocular lens implantation. A case-control study. Ophthalmology. 1995; 102:1925–31.
13). Kattan HM, Flynn HW Jr, Pflugfelder SC, et al. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology. 1991; 98:227–38.
14). Menikoff JA, Speaker MG, Marmor M, Raskin EM. A case-control study of risk factors for postoperative endophthalmitis. Ophthalmology. 1991; 98:1761–8.
crossref
15). Speaker MG, Milch FA, Shah MK, et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991; 98:639–49. discussion 650.
crossref
16). Mendicute J, Orbeqozo J, Ruiz M, et al. Keratomycosis after cataract surgery. J Cataract Refract Surg. 2000; 26:1660–6.
crossref
17). Garg P, Mahesh S, Bansal AK, et al. Fungal infection of sutureless self-sealing incision for cataract surgery. Ophthalmology. 2003; 110:2173–7.
crossref
18). Lalitha P, Prajna NV, Kabra A, et al. Risk factors for treatment outcome in fungal keratitis. Ophthalmology. 2006; 113:526–30.
crossref
19). Nagaki Y, Hayasaka S, Kadoi C, et al. Bacterial endophthalmitis after small-incision cataract surgery, effect of incision placement and intraocular lens type. J Cataract Refract Surg. 2003; 29:20–6.

Figure 1.
The frequency of wound infection after cataract surgery by year. It shows distribution of occurence in total 20 patients.
jkos-59-319f1.tif
Table 1.
Characteristics of patients with wound infection after cataract surgery
Variables Total patients (n = 20) Treatment success group (n = 13) Treatment failure group (n = 7) p-value
Age (years) 60.57 ± 12.14 58.74 ± 14.74 62.47 ± 13.66 0.641
Sex (male/female) Underlying disease 11 (55.0)/9 (45.0) 7 (53.85)/6 (46.15) 4 (57.14)/3 (42.86) 0.954
 Diabetes 5 (40.0) 1 (7.69) 4 (30.77) 0.025
 Hyperetension 10 (50.0) 6(46.15) 4 (30.77) 0.341
 Chronic kidney disease 3 (15.0) 2 (15.38) 1 (7.69) 0.145
 Immunocompromised state 2 (10.0) 1 (7.69) 1 (7.69) 0.214
Preoperative conditions
 Dry eye disease 7 (35.0) 4 (30.77) 3 (23.08) 0.214
 Meibomian gland dysfunction 6 (30.0) 4 (30.77) 2 (28.57) 0.423
 Nasolacrimal duct obstruction 4 (20.0) 2 (15.38) 2 (28.57) 0.316
History of ocular surgery
 Pterygium operation 7 (35.0) 4 (30.77) 3 (23.08) 0.214
 Refractive surgery 6 (30.0) 3 (23.07) 3 (23.08) 0.214
 Vitrectomy 4 (20.0) 2 (15.38) 1 (7.69) 0.474
Onset of symptoms/signs after surgery (days) 12.25 ± 20.21 (5–45) 14.47 ± 12.24 11.62 ± 9.24 0.475
Type of incision (corneal/scleral) 17 (85.0)/3 (15.0) 11/2 6/1 0.571
Incision location (temporal/superior) 12 (60.0)/8 (40.0) 8/5 4/3 0.743
Suture (yes/no) 6 (30.0)/14 (70.0) 2/11 4/3 0.034
Size of infiltration (mm2) 7.21 ± 9.41 (3–45) 3.16 ± 1.47 4.15 ± 1.13 0.130
Hypopyon (present/absent) 8 (40.0)/12 (60.0) 5/8 3/4 0.114
Combined endophthalmitis (present/absent) 6 (30.0)/14 (70.0) 3/10 3/4 0.001
Topical antibiotics use (yes/no) 4 (20.0)/16 (80.0) 3/10 1/6 0.064
Topical steroid use (yes/no) 7 (35.0)/13 (65.0) 4/9 3/4 0.036
Systemic steroid use (yes/no) 8 (40.0)/12 (60.0) 5/8 3/5 0.057
Microbiology results (bacteria/fungus) (bacteria:fungus) 16/4 12/1 4/3 0.029

Values are presented as mean ± standard deviation (range) or n (%) unless otherwise indicated.

Table 2.
Results of staining and culture in patients with wound infection after cataract surgery
Pathogens No. of cases Year of occurence
Bacteria 16
Staphylococcus epidermidis 4 (25.0) 2008, 2015 (2 cases), 2016
Staphylococcus aureus 3 (18.8) 2012, 2013, 2014
Streptococcus pneumonia 2 (12.5) 2005, 2012
Streptococcus viridans 2 (12.5) 2005, 2012
Enterobacter cloaca 1 (6.3) 2012
Klebsiella ornithinolytica 1 (6.3) 2007
Pseudomonas aeruginosa 1 (6.3) 2011
 No growth 2 (12.5) 2006, 2011
Fungus 4
Aspergillus species 2 (50.0) 2006, 2010
Candida albicans 1 (25.5) 2011
 No growth 1 (25.5) 2011

Values are presented as n (%) unless otherwise indicated.

Table 3.
Mean visual acuity at the time of presentation and final follow-up in the treatment success and treatment failure groups in patients with wound infection after cataract surgery
Variables Treatment success group (n = 13) Treatment failure group (n = 7) p-value
Baseline (logMAR) 1.88 ± 0.92 2.12 ± 0.84 0.065
Final follow-up (logMAR) (bacteria:fungus) 0.61 ± 0.36 1.70 ± 0.95 0.022

Values are presented as mean ± SD unless otherwise indicated.

Table 4.
Risk factors for treatment failure of wound infection after cataract surgery
Variable Univariate analysis
Multivariate analysis
OR (95% CI) p-value OR (95% CI) p-value
Diabetes (yes/no) 3.24 (1.01–4.74) 0.035 2.98 (1.30–6.19) 0.246
Suture (yes/no) 5.67 (2.47–7.87) 0.038 4.91 (1.78–9.56) 0.263
Combined endophthalmitis (yes/no) 12.56 (1.27–45.67) 0.001 12.47 (1.15–45.89) 0.001
Topical steroid use (yes/no) 7.78 (0.47–68.14) 0.057 6.11 (0.55–57.87) 0.464
Microbiology (fungus/bacteria) 5.21 (0.97–21.14) 0.021 5.17 (0.99–21.54) 0.044

OR = odds ratio; CI = confidence interval.

TOOLS
Similar articles